These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 967232)

  • 1. Sustained release of naltrexone from glyceride implants.
    Sullivan MF; Kalkwarf DR
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):27-32. PubMed ID: 967232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of naltrexone from glyceride implants.
    Sullivan MF; Kalkward DR
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):27-32. PubMed ID: 1234982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction.
    Schwope AD; Wise DL; Howes JF
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):13-8. PubMed ID: 787798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma corticosteroid levels in rats maintained on a long-acting naltrexone delivery system.
    Misra AL; Pontani RB; Vadlamani NL
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):43-50. PubMed ID: 663407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists.
    Sidman KR; Arnold DL; Steber WD; Nelsen L; Granchelli FE; Strong P; Sheth SG
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):33-8. PubMed ID: 1234983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Chronomers for narcotic antagonists.
    Capozza RC; Schmitt EE; Sendelbeck LR
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):39-42. PubMed ID: 13306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid solutions as long-acting naltrexone delivery systems.
    Olsen JL
    NIDA Res Monogr; 1981; 28():265-71. PubMed ID: 6791010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved long-acting delivery system for narcotic antagonists.
    Misra AL; Pontani RB
    NIDA Res Monogr; 1981; 28():254-64. PubMed ID: 6791009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of drug delivery systems for use in the treatment of narcotic addiction.
    Reuning RH; Malspeis L; Frank S; Notari RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):43-5. PubMed ID: 827709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction.
    Schwope AD; Wise DL; Howes JF
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):13-8. PubMed ID: 1241970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.
    He GA; Hou HM; Liu XJ
    Acta Pharmacol Sin; 2001 Jun; 22(6):530-3. PubMed ID: 11747760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of parenteral sustained-release naltrexone systems.
    Olsen JL; Kincl FA
    NIDA Res Monogr; 1981; 28():187-93. PubMed ID: 6791004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Chronomers tm for narcotic antagonists.
    Capozza RC; Schmitt EE; Seńdelbeck LR
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):39-42. PubMed ID: 967234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcotic antagonists: naltrexone pharmacochemistry and sustained-release preparations.
    NIDA Res Monogr; 1981; 28():1-273. PubMed ID: 6790998
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of drug delivery systems for use in treatment of narcotic addiction.
    Sharon AC; Wise DL
    NIDA Res Monogr; 1981; 28():194-213. PubMed ID: 6791005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists.
    Sidman KR; Arnold DL; Steber WD; Nelsen L; Granchelli FE; Strong P; Sheth SG
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):33-8. PubMed ID: 967233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic quantitation of naltrexone release from several sustained-release delivery systems.
    Reuning RH; Liao SH; Staubus AE
    NIDA Res Monogr; 1981; 28():172-84. PubMed ID: 6791003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone, morphine and cocaine interactions in mice and rats.
    Blumberg H; Ikeda C
    J Pharmacol Exp Ther; 1978 Aug; 206(2):303-10. PubMed ID: 682114
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1976 Sep; (9):31-4. PubMed ID: 1004531
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of injectable microcapsules for use in the treatment of narcotic addiction.
    Thies C
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):19-20. PubMed ID: 1241971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.